|
| |
Xcyte Therapie Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioSpace - Xcyte Therapies, Inc. News, Search Jobs, Events
Xcyte Therapies, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock 10/19/2005 5:13:16 PM More. ...
http://www.biospace.com/company_profile.aspx?CompanyId=2876...
|
BioPortfolio - Xcyte Therapies Incorporated
4 Nov 2008 ... Xcyte Therapies Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/11082-Xcyte_Therapi...
|
Xcyte Therapies, Inc. Stockholders Approve Transaction With Cycla ...
SEATTLE--(BUSINESS WIRE)--March 16, 2006--Xcyte Therapies, Inc. (Xcyte, the " Company") (NASDAQ:XCYT) (NASDAQ:XCYTP) announced that at a special meeting held
...
http://www.biospace.com/news_story.aspx?NewsEntityId=12839...
|
BioPortfolio - xcyte therapies inc. 1124 columbia street
Stewart CRAIG, Chief Operating Officer & Vice President, Xcyte Therapies, Inc., ... Xcyte Therapies, Inc. 2203 Airport Way S. Suite 300 Seattle, WA 98143 . ...
http://www.bioportfolio.com/search/xcyte_therapies_inc._1124...
|
Molecular Therapy - Abstract of article: 707. Transduction and ...
In order to conduct a clinical trial of adoptive therapy with genetically ... Significantly, the biologic activity of the T cells activated with Xcyte ...
http://www.nature.com/mt/journal/v11/n1s/abs/mt2005827a.html...
|
BioPortfolio - Xcyte Therapies Incorporated - Profile
View the current Xcyte Therapies Incorporated Page on BioPortfolio.com ... Xcyte Therapies has an experienced management team with a proven track record of ...
http://www.bioportfolio.com/biocorporate/11082-Xcyte+Therapi...
|
Molecular Therapy - Abstract of article: 709. Comparison of the ...
1Division of Oncology, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO; 2Xcyte Therapies, Inc., Seattle, WA ...
http://www.nature.com/mt/journal/v11/n1s/abs/mt2005829a.html...
|
BioPortfolio - BioPortfolio - Xcyte Therapies Incorporated
BioPortfolio - Xcyte Therapies Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/11082/www.x...
|
2004N-0408 - Regulatory Site Visit Training Program FDA Comment ...
Xcyte Therapies would like to request consideration under Docket No. ... Xcyte Therapies is a Seattle-based biotechnology company developing cellular ...
http://www.fda.gov/OHRMS/DOCKETS/dockets/04n0408/04N-0408-EC...
|
Molecular Therapy - Abstract of article: 810. Ex-Vivo Activation ...
1Oncology, Washington University School of Medicine, Saint Louis, MO; 2Xcyte Therapies, Inc., Seattle, WA. |[ast]|MB is an employee of Xcyte Therapies, ...
http://www.nature.com/mt/journal/v11/n1s/abs/mt2005930a.html...
|
|
